A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

This first-in-human trial is testing a highly unconventional method: delivering fat-derived stem cells from the patient ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

This research roundup discusses researchers’ attempts to find a treatment for a “brain fog” that comes with CAR T-Cell ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

Immatics’ cell therapy has been linked to a 56% objective response rate (ORR) among 32 heavily pretreated patients with ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma. A next-generation "armored" CAR T cell therapy ...

Now, that same therapy is available at St. George Regional Hospital's Cancer Center, which Jacqueline said is "just down the street" from her. CAR-T cell therapy, also known as chimeric antigen ...

IT’S NOT CURABLE AT THIS POINT. RUNNING OUT OF OPTIONS, HE TRIED A RELATIVELY NEW TREATMENT CALLED CAR-T CELL THERAPY, USING HIS OWN CELLS TO FIGHT THE DISEASE. THE STARTING MATERIALS ...